To keep up with the most reliable environment news source, subscribe to our newsletter and follow us on social media. Imagine ...

MONTREAL, Jan. 13, 2025 (GLOBE NEWSWIRE) -- (TSX: RAY.A; RAY.B) will release its financial results for the third quarter ...

The hefty tariffs President-elect Trump has pledged to levy on U.S. imports could impact the price and availability of pharmaceutical drugs. Trump has floated 25 percent tariffs on imports from ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...

A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022. The over 250 drug hikes represent an increase from ...

This scenario indicates that 2025 will be a promising year for the pharma sector. A report by Axis Securities last month outlined a positive outlook for the pharmaceutical sector over the next three ...

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed ...

STOCKHOLM & RADNOR, Pa.--(BUSINESS WIRE)--$MRNS #MarinusPharma--Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc ...

On November 14, BYDDY entered into a strategic partnership with The Singing Machine Company, Inc., a subsidiary of Algorhythm Holdings, Inc., along with Stingray. Under the terms of the agreement, ...

Vertex Pharmaceuticals is trying to diversify its product portfolio. One of the programs it's working on aims to treat pain in a few contexts. There's reason to believe that it won't be effective ...

Mirum Pharmaceuticals has three approved products and a promising pipeline, with volixibat showing superior interim data for PBC compared to competitors. It is a buy for volixibat's potential ...